Is melatonin Safe with cytotoxic chemotherapy (general)?
Free · No account · based on published sources including NIH ODS, FDA drug labels, and peer-reviewed literature
Melatonin supplementation during breast cancer chemotherapy appears generally safe and may reduce treatment-related toxicities; however, discuss with your oncologist before starting, as evidence is not universal and depends on tumor biology and specific regimen.
Why this interaction occurs
Unlike some antioxidants that can neutralize essential reactive oxygen species (ROS) required for cytotoxic chemotherapy efficacy (increasing recurrence and mortality risk), melatonin has been specifically identified as an antioxidant intervention that ameliorates treatment-induced toxicities without compromising therapeutic efficacy in breast cancer management.
Evidence
Evidence level: moderate.
Data source
PubMed - PMID 42123930
Reported safety data
The FDA’s adverse event reporting system (FAERS) has received 1,355,039 reports mentioning cytotoxic chemotherapy (general). This reflects reported cases involving the medication in general — not confirmed causation, and not specific to the cytotoxic chemotherapy (general) + supplement combination on this page.
FAERS reports are voluntary and cannot prove that a drug caused an event. Do not use report counts to assess the safety of this specific drug-supplement pair.
Frequently asked questions
Related interactions
All melatonin interactions → · All cytotoxic chemotherapy (general) interactions →
Already checked this one — check your whole list
Educational only — not medical advice.
Always confirm with your doctor or pharmacist.